Estradiol plus drospirenone therapy increases mammographic breast density in perimenopausal women

E2/DRSP therapy for 12 months in perimenopausal women significantly increased mammographic breast density in comparison to a control group. Further long-term and large scale prospective studies are needed to evaluate this issue.